Lifestyle Features

Jana urges Cooper to replace CEO, explore asset sales after performance setbacks

Reuters  |  Updated Sept. 18 - 11:10 a.m.  |  Save Story

Activist investor Jana Partners on Friday urged Cooper Companies to launch ​an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence ‌and weighed on the medical device maker's market value.

US pharmacy chain Walgreens plans tech centre in India's Chennai, expected to create 250 jobs

Reuters  |  Posted Sept. 18 - 1:53 a.m.  |  Save Story

US-based pharmacy chain Walgreens ​plans to establish a new Global Capability Centre (GCC) ‌in Chennai, the capital of the ⁠southern Indian ​state of ⁠Tamil Nadu.

Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine

Reuters  |  Updated Sept. 17 - 9:55 p.m.  |  Save Story

Dr Reddy's Laboratories said on ​Friday it had signed an agreement with Japanese drugmaker Takeda Pharmaceutical ‌to promote and distribute the Qdenga dengue ⁠vaccine in India.

SPONSORED

This year's AARP Andrus Award recipient finds purpose through music and community

VideoTamara Vaifanua, KSL  |  Updated Sept. 17 - 4:35 p.m.  |  Save Story

Alice Cipollini, 80, shows how a life of service has no age limit.

Virbac confirms outlook as Supercharge platforms drive profit growth

Reuters  |  Updated Sept. 17 - 10:37 a.m.  |  Save Story

French animal health company Virbac reported higher ​half-year core profit on Thursday with a recurring operating profit, excluding amortization of ‌assets due to acquisitions, rising 6.8% to 144.2 million euros ($165.50 ⁠million), compared with 135.0 ​million euros a ⁠year earlier.

Advent to invest $328.5 million in India's Yatharth Hospital for 24.9% stake

Reuters  |  Updated Sept. 17 - 9:10 a.m.  |  Save Story

U.S.-based private equity firm Advent International ​said on Thursday it will invest 31.5 billion rupees ($328.53 million) in Yatharth ‌Hospital for a 24.9% stake, sending shares of the ⁠Indian hospital operator ​to a record ⁠high.

Novo, Orbis sign up to $1.4 billion deal to develop oral drugs

Siddhi Mahatole, Reuters  |  Updated Sept. 17 - 9:05 a.m.  |  Save Story

Orbis Medicines said on Thursday it had signed a drug ​discovery and licensing agreement worth up to $1.4 billion with Novo Nordisk to develop oral therapies for cardiometabolic diseases, traditionally treated ‌with injectable drugs.

Healthcare firm Ramsay Generale de Sante sees 2027 revenue rising by up to 3%

Reuters  |  Posted Sept. 17 - 12:27 a.m.  |  Save Story

French healthcare ​provider Ramsay Generale de Sante ‌expects its revenue to ⁠grow ​by 2% ⁠to 3% ‌in 2027, ‌with a stable ⁠core ⁠profit margin compared to 2026, it said ahead of its capital ‌markets day ​on Thursday.

Novartis halts ALS drug development after mid-stage trial failure

Sriparna Roy, Reuters  |  Updated Sept. 16 - 2:31 p.m.  |  Save Story

Novartis has halted development of an experimental drug for amyotrophic ​lateral sclerosis after it failed to meet goals in a mid-stage study, marking the latest disappointment for the Swiss drugmaker this ‌year.

Ebola response making progress in Congo, but outbreak 'far from over,' WHO says

Siddhi Mahatole, Reuters  |  Updated Sept. 16 - 8:47 a.m.  |  Save Story

The World Health Organization said on Wednesday there were encouraging signs ​measures to contain an Ebola epidemic in Democratic Republic of Congo were gaining ground, though it warned the outbreak was "far from ‌over."

Sling Therapeutics raises $123 million to advance thyroid eye disease drug

Kunal Das and Siddhi Mahatole, Reuters  |  Updated Sept. 16 - 8:10 a.m.  |  Save Story

Drug developer Sling Therapeutics said on ​Wednesday it had raised $123 million to advance a late-stage trial of its experimental oral drug to treat thyroid eye ‌disease.

Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs

Richa Naidu, Reuters  |  Updated Sept. 16 - 8:03 a.m.  |  Save Story

Consumer health company Haleon has achieved growing sales of ​products to counter side-effects of weight-loss drugs in the United States, the company said, capitalising on the rising popularity ‌of GLP-1 medication.

ByteDance completes $290 million fundraising for AI drug unit after its spin-off, sources say

Kane Wu, Reuters  |  Updated Sept. 16 - 8:03 a.m.  |  Save Story

Chinese social media and internet company ByteDance has ​completed a $290 million fundraising for its AI drugmaking unit after spinning it off from the group, two people with ‌knowledge of the matter said on Wednesday.

Novo partners with Anthropic to speed up drug development with Claude

Reuters  |  Updated Sept. 16 - 8:01 a.m.  |  Save Story

Novo Nordisk has partnered with Anthropic to use ​the AI giant's Claude models to speed up discovery and development of new medicines, the ‌companies said on Wednesday.

American incomes finally top pre-pandemic levels, fighting against inflation all the way

Christopher Rugaber, Associated Press  |  Updated Sept. 15 - 8:03 p.m.  |  Save Story

Household income finally topped pre-pandemic levels last year, a stark sign of how the past five years of rising prices have limited Americans' earnings and purchasing power.

Pennsylvania measles-associated deaths climb to four as outbreak grows

Sriparna Roy and Kamal Choudhury, Reuters  |  Updated Sept. 15 - 3:16 p.m.  |  Save Story

The Pennsylvania Department of Health on Tuesday reported two more measles-associated deaths, both in unvaccinated individuals, bringing the state's total fatalities linked ​to the disease outbreak to four.

This country is paying its people to read. Can it stop 'brain rot'?

Kathleen Magramo, CNN  |  Updated Sept. 15 - 3:04 p.m.  |  Save Story

Whether it's while waiting for the train or chilling solo at a cafe, a tiny nation in Southeast Asia is nudging its people toward an increasingly elusive habit: reading.

Legend Biotech taps Novartis veteran Zhang as CEO

Siddhi Mahatole, Reuters  |  Updated Sept. 15 - 2:22 p.m.  |  Save Story

Legend Biotech on Tuesday appointed longtime Novartis executive Ingrid Zhang as ​its CEO, effective immediately, banking on an industry veteran to steer its expansion beyond blockbuster cancer therapy Carvykti.

For the first time, Japan has more than 100,000 centenarians

Chris Lau and Junko Ogura, CNN  |  Updated Sept. 15 - 11:36 a.m.  |  Save Story

Japan has been gripped by a declining population for decades, but one age group is adding new members, and there are more of them than ever — centenarians.